Syndrome. Losartan will be the 1st remedy targeting the underlying aortic pathophysiology
Syndrome. Losartan will be the first treatment targeting the underlying aortic pathophysiology in Marfan syndrome and is efficient in minimizing aortic dilatation rate in patients and mice with Marfan syndrome…